semaglutide side effect lawsuit in michigan Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Lawsuits claiming Ozempic, other GLP-1s

They treated 8 pouchees with the GLP-1 drug Liraglutide (trade name Saxenda ) in a well-designed, placebo-controlled, double-blind, cross-over clinical trial and showed a 35% reduction in toilet frequency on treatment compared to placebo, a reduction in urgency and better stool consistency and the drug was safe and well tolerated

doi: 10.1073/pnas.2105465118 87 SiuTAltmanMDBaltusGAChildersMEllisJMGunaydinHet al

Once the catheter is in the right place, your IR doctor will start the embolization

Early trial data shows remarkable weight loss approaching 25% with the highest doses tested

Wegovy works by acting as a GLP-1 receptor agonist